Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle

Aims/hypothesisInsulin resistance in skeletal muscle is linked to mitochondrial dysfunction in obesity and type 2 diabetes. Emerging evidence indicates that reversible phosphorylation regulates oxidative phosphorylation (OxPhos) proteins. The aim of this study was to identify and quantify site-specific phosphorylation of the catalytic beta subunit of ATP synthase (ATPsyn-β) and determine protein abundance of ATPsyn-β and other OxPhos components in skeletal muscle from healthy and insulin-resistant individuals.MethodsSkeletal muscle biopsies were obtained from lean, healthy, obese, non-diabetic and type 2 diabetic volunteers (each group n = 10) for immunoblotting of proteins, and hypothesis-driven identification and quantification of phosphorylation sites on ATPsyn-β using targeted nanospray tandem mass spectrometry. Volunteers were metabolically characterised by euglycaemic–hyperinsulinaemic clamps.ResultsSeven phosphorylation sites were identified on ATPsyn-β purified from human skeletal muscle. Obese individuals with and without type 2 diabetes were characterised by impaired insulin-stimulated glucose disposal rates, and showed a ∼30% higher phosphorylation of ATPsyn-β at Tyr361 and Thr213 (within the nucleotide-binding region of ATP synthase) as well as a coordinated downregulation of ATPsyn-β protein and other OxPhos components. Insulin increased Tyr361 phosphorylation of ATPsyn-β by ∼50% in lean and healthy, but not insulin-resistant, individuals.Conclusions/interpretationThese data demonstrate that ATPsyn-β is phosphorylated at multiple sites in human skeletal muscle, and suggest that abnormal site-specific phosphorylation of ATPsyn-β together with reduced content of OxPhos proteins contributes to mitochondrial dysfunction in insulin resistance. Further characterisation of phosphorylation of ATPsyn-β may offer novel targets of treatment in human diseases with mitochondrial dysfunction, such as diabetes.

[1]  J. Dixon,et al.  Mitochondrial modulation: reversible phosphorylation takes center stage? , 2006, Trends in biochemical sciences.

[2]  C. Wollheim,et al.  Mitochondrial function in normal and diabetic beta-cells. , 2001, Nature.

[3]  A. Brunati,et al.  Tyrosine phosphorylation in mitochondria: a new frontier in mitochondrial signaling. , 2005, Free radical biology & medicine.

[4]  Albert Sickmann,et al.  Profiling Phosphoproteins of Yeast Mitochondria Reveals a Role of Phosphorylation in Assembly of the ATP Synthase*S , 2007, Molecular & Cellular Proteomics.

[5]  K. Sahlin,et al.  Mitochondrial dysfunction in type 2 diabetes and obesity. , 2008, Endocrinology and metabolism clinics of North America.

[6]  J. Mei,et al.  Consumption of soy protein isolate modulates the phosphorylation status of hepatic ATPase/ATP synthase beta protein and increases ATPase activity in rats. , 2007, The Journal of nutrition.

[7]  Young-sil Yoon,et al.  Mitochondria are impaired in the adipocytes of type 2 diabetic mice , 2006, Diabetologia.

[8]  John C Reed,et al.  The bioenergetic signature of cancer: a marker of tumor progression. , 2002, Cancer research.

[9]  D. Wallace.  A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[10]  K. Petersen,et al.  Decreased Insulin-Stimulated ATP Synthesis and Phosphate Transport in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Parents , 2005, PLoS medicine.

[11]  Tom D. Bunney,et al.  14-3-3 protein is a regulator of the mitochondrial and chloroplast ATP synthase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Højlund,et al.  Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes , 2006, Diabetologia.

[13]  G. Nowak,et al.  Protein kinase C-alpha inhibits the repair of oxidative phosphorylation after S-(1,2-dichlorovinyl)-L-cysteine injury in renal cells. , 2004, American journal of physiology. Renal physiology.

[14]  R. Mottram.  The oxygen consumption of human skeletal muscle in vivo , 1955, The Journal of physiology.

[15]  L. Casano,et al.  Multiple phosphorylation sites in the β subunit of thylakoid ATP synthase , 2006, Photosynthesis Research.

[16]  R. Berria,et al.  Global relationship between the proteome and transcriptome of human skeletal muscle. , 2008, Journal of proteome research.

[17]  K. Højlund,et al.  Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes? , 2006, Current diabetes reviews.

[18]  D. Hardie,et al.  Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes. , 2003, Diabetes.

[19]  S. Knudsen,et al.  Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome , 2007, Diabetes.

[20]  D. K. Arrell,et al.  Proteomic Analysis of Pharmacological Preconditioning: Novel Protein Targets Converge to Mitochondrial Metabolism Pathways , 2006, Circulation research.

[21]  L. Casano,et al.  Multiple phosphorylation sites in the beta subunit of thylakoid ATP synthase. , 2006, Photosynthesis research.

[22]  Wayne F. Patton,et al.  Analysis of Steady-state Protein Phosphorylation in Mitochondria Using a Novel Fluorescent Phosphosensor Dye* , 2003, Journal of Biological Chemistry.

[23]  L. Mandarino,et al.  Quantification of phosphorylation of insulin receptor substrate-1 by HPLC-ESI-MS/MS , 2006, Journal of the American Society for Mass Spectrometry.

[24]  Susan T Weintraub,et al.  Identification of phosphorylation sites in insulin receptor substrate-1 by hypothesis-driven high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. , 2005, Analytical chemistry.

[25]  Y. Miyazaki,et al.  Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients. , 2003, Diabetes.

[26]  T. Hunter,et al.  Signaling—2000 and Beyond , 2000, Cell.

[27]  Mitsuaki Yanagida,et al.  Matrix assisted laser desorption/ionization‐time of flight‐mass spectrometry analysis of proteins detected by anti‐phosphotyrosine antibody on two‐dimensional‐gels of fibrolast cell lysates after tumor necrosis factor‐α stimulation , 2000 .

[28]  B. Wolf,et al.  Leucine Culture Reveals That ATP Synthase Functions as a Fuel Sensor in Pancreatic β-Cells* , 2004, Journal of Biological Chemistry.

[29]  Aase Handberg,et al.  Proteome Analysis Reveals Phosphorylation of ATP Synthase β-Subunit in Human Skeletal Muscle and Proteins with Potential Roles in Type 2 Diabetes* , 2003, The Journal of Biological Chemistry.

[30]  C. Flynn,et al.  Characterization of the Human Skeletal Muscle Proteome by One-dimensional Gel Electrophoresis and HPLC-ESI-MS/MS*S , 2008, Molecular & Cellular Proteomics.

[31]  F. Lottspeich,et al.  Tumor Necrosis Factor α Inhibits Oxidative Phosphorylation through Tyrosine Phosphorylation at Subunit I of Cytochrome c Oxidase* , 2008, Journal of Biological Chemistry.

[32]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Samavati,et al.  Regulation of mitochondrial oxidative phosphorylation through cell signaling. , 2007, Biochimica et biophysica acta.

[34]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[35]  Joris Hoeks,et al.  Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients , 2008, Diabetes.

[36]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[37]  F. López-Ríos,et al.  Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. , 2007, Cancer research.

[38]  Min-Seon Kim,et al.  Essential Role of Mitochondrial Function in Adiponectin Synthesis in Adipocytes , 2007, Diabetes.

[39]  H. Beck-Nielsen,et al.  Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes , 2001, Diabetologia.

[40]  Robert A. Harris,et al.  Use of (32)P to study dynamics of the mitochondrial phosphoproteome. , 2009, Journal of proteome research.

[41]  K. Sahlin,et al.  Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes , 2007, Diabetes.

[42]  C. Flynn,et al.  Global Assessment of Regulation of Phosphorylation of Insulin Receptor Substrate-1 by Insulin In Vivo in Human Muscle , 2007, Diabetes.

[43]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[44]  Matthias Wjst,et al.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2005, Methods in molecular biology.

[45]  Peter Nowotny,et al.  Muscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes , 2007, PLoS medicine.

[46]  B. Lowell,et al.  Mitochondrial Dysfunction and Type 2 Diabetes , 2005, Science.

[47]  K. Nair,et al.  Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Boushel,et al.  Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.

[49]  Frank A Witzmann,et al.  Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium. , 2006, Biochemistry.

[50]  C. Kahn,et al.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.

[51]  B. Goodpaster,et al.  Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. , 2005, Diabetes.